Veritas, AZB act on Swedish firm Recipharm's acquisition of Kemwell businessesApril 21 2016
Recipharm AB, a Swedish a pharmaceutical contract development and manufacturing organisation (CDMO) is acquiring Kemwell’s CDMO businesses in India, US and Sweden in a strategic deal worth $ 205 million (1360 crore).
Veritas Legal acted for Recipharm with a team led by Partner Nandish Vyas along with Associates, Natasha Sethna and Tejasvi Saxena.
AZB & Partners acted for Kemwell and the team included Partners Srinath Dasari and Nanditha Gopal and Associates Bhuvana Veeraragavan . . .
You need to have an active subscription to view this content.
With a premium account you get:
- One year of unrestrcited access to previous interviews, columns and articles
- One year access to all archival material
- Access to all Bar & Bench reports